Speaker profile

Dylan Maixner

VP, Consulting
Rancho BioSciences

Dylan Maixner is Vice President of Consulting at Rancho BioSciences, where he helps life sciences organizations define, operationalize, and scale their R&D data strategies. He partners with R&D companies on enabling enterprise data strategies, operationalizing new governance structures, and preparing organizations for future process, technology, and skillset changes. Before joining Rancho, Dylan was part of Accenture’s Global Life Sciences practice, advising biopharma companies on data and digital transformation programs. His scientific experience includes research at the National Institutes of Health in the Laboratory for Human Neurogenetics and industry work developing a personalized genetic pain panel. Dylan holds a PhD in Pharmaceutical and Biomedical Sciences and an MBA from the University of Georgia, and a BS in Biology from the University of North Carolina at Chapel Hill.

Agenda sessions

Day 2 | September 23, 2026
14:35 (CEST)
Realizing Value from AI in Pharma R&D : Why Decision Velocity Matters
Go to session
14:50 (CEST)
Panel Discussion and Q&A
Go to session